tutye hands gloves ppe

PHE/DH/DWP guideline

UKHSA IPC for seasonal respiratory infections guideline

2022-05-04T09:45:00+01:00By UK Health Security Agency, DHSC, Public Health Wales, Public Health Agency Northern Ireland, NHS National Services Scotland, NHS England

Covering the infection prevention and control principles required to prevent transmission of COVID-19 and other respiratory viruses for winter 2021–2022

Maridav cough doctor sneeze staff covid

PHE/DH/DWP guideline

UKHSA staff with symptoms of a respiratory infection guideline

2022-04-12T10:42:00+01:00By UK Health Security Agency

Covering the management of healthcare staff with symptoms of a respiratory infection, including COVID-19 and positive COVID-19 test results

blue lung red circulation outline-min

Independent professional body guideline

GOLD COPD 2022 strategy

2022-02-18T08:41:00+00:00By

A clear summary of GOLD’s 2022 strategy on COPD diagnosis, management, and prevention, including recommendations on COVID-19 and COPD 

man sleeping with CPAP machine on_165059625_kudosstudio

NICE guideline

NICE obstructive sleep apnoea guideline

2021-09-28T11:22:00+01:00By

Covering the diagnosis and management of OSAHS, and the assessment of OHS and COPD–OSAHS overlap syndrome in people over 16

Baby being examined by a doctor

NICE guideline

NICE bronchiolitis guideline

2021-08-13T13:20:00+01:00By

A brief summary of the NICE guideline on bronchiolitis in babies and children, including advice on when to refer, and 'red flags' for parents

AdobeStock_158900630

NICE guideline

NICE asthma guideline: chronic asthma management

2021-04-23T14:55:00+01:00

A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms

Man with inhaler

NICE guideline

NICE asthma guideline: diagnosis and monitoring

2021-04-20T12:45:00+01:00By

A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms

AdobeStock_301114385

NICE guideline

COVID-19 rapid guideline on cystic fibrosis

2020-10-12T14:26:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.

AdobeStock_212764468

Working party guideline/algorithm

Identifying and managing allergic rhinitis in the asthma population

2020-08-23T04:00:00+01:00By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

An inhaler in WPG Yellow

Working party guideline/algorithm

Inhaler choice guideline

2020-07-31T08:50:00+01:00By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.

Resource hub

  • Inhaler standards and competency document

Educational resources

DuoResp Spiromax (budesonide:formoterol) prescribing summary card

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited on 0207 540 7117 or medinfo@tevauk.com.

Click here for prescribing information and adverse event reporting

DUOR-GB-00117
Date of preparation: March 2022

AdobeStock_212764468

Identifying and managing allergic rhinitis in the asthma population

By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

An inhaler in WPG Yellow

Inhaler choice guideline

By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.